AI drug discovery startup goes public in Hong Kong, nabbing $115M to build on pharma partnerships
Chinese AI drug discovery company XtalPi has landed on the Hong Kong stock exchange after nearly $115 million ($896.13 million HKD) from an IPO. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
